HealthQuill Drugs
AstraZeneca signed a $245 million deal with a French clinical-stage biotechnology firm, Cellectis, to speed up therapeutics in oncology, immunology and rare diseases.
Drugs Health Pharma

AstraZeneca inks $245 million deal with Cellectis for rare diseases

HQ Team November 1, 2023: AstraZeneca signed a $245 million deal with a French clinical-stage biotechnology firm, Cellectis, to speed up therapeutics in.

Read More
Research uncovers significant discrepancies in ingredient labels and presence of banned compounds
Drugs Medical Pharma

Clovibactin: A novel antibiotic with greater resistance

HQ Team November 1, 2023: A collaboration between the University of Bonn, Utrecht University, and Northeastern University in Boston, alongside NovoBiotic Pharmaceuticals, has.

Read More
The US’s medical research agency has discovered more than 3,000 new types of brain cells in different clusters of the organ that may help in the treatment of cancer and neurodegenerative diseases.
Drugs Health Pharma

NIH researchers find 3,000 new brain cells, create ‘most detailed’ atlas

HQ Team November 1, 2023: The US’s medical research agency has discovered more than 3,000 new types of brain cells in different clusters.

Read More
Drugs Medical Pharma

FDA approves Santhera’s Agamree for Duchenne muscular dystrophy

HQ team October 31, 2023: The US Food and Drug Administration (FDA) has given the green light to Santhera Pharmaceuticals’ drug, Agamree (vamorolone),.

Read More
The US Food and Drug Administration has warned consumers not to use certain over-the-counter eye drop products due to the potential risk of infections.
Drugs Health Pharma

FDA warns against use of certain OTC eye drop products

HQ Team October 31, 2023: The US Food and Drug Administration has warned consumers not to use certain over-the-counter eye drop products due.

Read More
Shingles can strike anywhere on your body and it most often appears as a single stripe of blisters that wraps around either the left or the right side of the human torso. At times the pain is excruciating. 
Drugs Health Pharma

Opinion: ‘I want to press the area with a hot iron box’: Shingles patient

By Dr K. Leelamoni October 31, 2023: During an annual family temple festival, celebrated at my ancestral home in the southern Indian state.

Read More
Drugs Health Medical

IISER scientists develop biomedical adhesive for tissue healing

HQ Team October 30, 2023: Researchers at the Indian Institute of Science Education and Research Bhopal (IISER) have developed a transparent biomedical adhesive.

Read More
Anixa Biosciences, Inc., announced that its partner Cleveland Clinic has begun enrolling subjects in a treatment arm to evaluate the combination of the company's breast cancer vaccine with Merck’s Keytruda (pembrolizumab) immunotherapy.
Drugs Health Medical Pharma

GSK’s Jemperli shows promise in treating endometrial cancer

HQ Team October 30, 2023: GSK plc has announced significant findings from a phase III trial trial for Jemperli (dostarlimab), a potential treatment for.

Read More
Drugs Health Medical

Researchers uncover the role of dynein in breast cancer metastasis

HQ Team October 30, 2023: Researchers have unraveled a critical mechanism involving the dynein protein, shedding light on how it aids the spread.

Read More
The receptor of Oxytocin, a hormone considered essential to forming social bonds, may not play the role that scientists have assigned it for the past 30 years, according to US scientists.
Drugs Health Medical Pharma

Gene therapy cure for sickle cell awaits advisory approval

HQ Team October 28, 2023: Advisers to the Food and Drug Administration (FDA) are set to review a gene therapy for sickle cell.

Read More